Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Raised to $753 at Bernstein SocGen Group

August 4, 2025 9:22 AM
Bernstein SocGen Group analyst William Pickering raised the price target on Regeneron Pharma (NASDAQ: REGN) to $753.00 (from $750.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles